In conclusion, this is the first study, to our knowledge, that demonstrates the expression of ADAMs in SCLC patients and confirms that ADAM-12 is an independent prognostic factor and an effective diagnostic marker that is involved in SCLC proliferation, invasion and metastasis. This evidence concerns the gene ADAM12 and small cell lung carcinoma.